RHÖN-KLINIKUM Aktiengesellschaft Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/15/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume167 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RKAGY News and Ratings via Email

Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

RHÖN-KLINIKUM Aktiengesellschaft logo

About RHÖN-KLINIKUM Aktiengesellschaft

Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. Outpatient-inpatient basic and standard care is offered in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.


No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) Frequently Asked Questions

What stocks does MarketBeat like better than RHÖN-KLINIKUM Aktiengesellschaft?

Wall Street analysts have given RHÖN-KLINIKUM Aktiengesellschaft a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but RHÖN-KLINIKUM Aktiengesellschaft wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has RHÖN-KLINIKUM Aktiengesellschaft's stock price been impacted by Coronavirus (COVID-19)?

RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RKAGY stock has decreased by 5.6% and is now trading at $9.50.
View which stocks have been most impacted by COVID-19

Who are RHÖN-KLINIKUM Aktiengesellschaft's key executives?

RHÖN-KLINIKUM Aktiengesellschaft's management team includes the following people:
  • Christian Höftberger, Chairman-Management Board
  • Gunther K. Weiß, Chief Operating Officer
  • Stefan Stranz, Chief Financial Officer
  • Bernd Griewing, Chief Marketing Officer
  • Nina Knauer, Head-Marketing

Who are some of RHÖN-KLINIKUM Aktiengesellschaft's key competitors?

What is RHÖN-KLINIKUM Aktiengesellschaft's stock symbol?

RHÖN-KLINIKUM Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "RKAGY."

How do I buy shares of RHÖN-KLINIKUM Aktiengesellschaft?

Shares of RKAGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RHÖN-KLINIKUM Aktiengesellschaft's stock price today?

One share of RKAGY stock can currently be purchased for approximately $9.50.

How many employees does RHÖN-KLINIKUM Aktiengesellschaft have?

RHÖN-KLINIKUM Aktiengesellschaft employs 18,368 workers across the globe.

What is RHÖN-KLINIKUM Aktiengesellschaft's official website?

The official website for RHÖN-KLINIKUM Aktiengesellschaft is www.rhoen-klinikum-ag.com.

Where are RHÖN-KLINIKUM Aktiengesellschaft's headquarters?

RHÖN-KLINIKUM Aktiengesellschaft is headquartered at Schlossplatz 1, Bad Neustadt An Der Saale, Bayern 97616.

How can I contact RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft's mailing address is Schlossplatz 1, Bad Neustadt An Der Saale, Bayern 97616. The company can be reached via phone at 499771650.

This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.